Problems

What will AGI do for Immunotherapy Patient Adherence?

Immunotherapy requires strict adherence to dosing schedules, but immune-related adverse events routinely derail treatment plans. Oncology clinics and care coordinators struggle to keep patients on therapy because side effects develop unpredictably between scheduled infusions. Patients frequently skip doses or abandon treatment entirely when managing these toxicities becomes overwhelming, directly compromising their clinical outcomes and wasting high-cost specialty drugs.